Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V, Mark, Tomer M, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K, Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A Kate, Schecter, Jordan M, Mateos, Maria-Victoria
Published in Haematologica (Roma) (01.12.2018)
Published in Haematologica (Roma) (01.12.2018)
Get full text
Journal Article
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Weisel, Katja, Spencer, Andrew, Lentzsch, Suzanne, Avet-Loiseau, Hervé, Mark, Tomer M, Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay, Quach, Hang, Munder, Markus, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Chanan-Khan, Asher A, Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Casneuf, Tineke, DeAngelis, Nikki, Amin, Himal, Ukropec, Jon, Kobos, Rachel, Mateos, Maria-Victoria
Published in Journal of hematology and oncology (20.08.2020)
Published in Journal of hematology and oncology (20.08.2020)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K., Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V., Mark, Tomer M., Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Evaluation of sustained minimal residual disease negativity with daratumumab-combination regimens in relapsed and/or refractory multiple myeloma: analysis of POLLUX and CASTOR
Avet-Loiseau, Hervé, San-Miguel, Jesus, Casneuf, Tineke, Iida, Shinsuke, Lonial, Sagar, Usmani, Saad Z, Spencer, Andrew, Moreau, Philippe, Plesner, Torben, Weisel, Katja, Ukropec, Jon, Chiu, Christopher, Trivedi, Sonali, Amin, Himal, Krevvata, Maria, Ramaswami, Priya, Qin, Xiang, Qi, Mia, Sun, Steven, Qi, Ming, Kobos, Rachel, Bahlis, Nizar J
Published in Journal of clinical oncology (01.04.2021)
Published in Journal of clinical oncology (01.04.2021)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR
Mateos, Maria-Victoria, Sonneveld, Pieter, Hungria, Vania, Nooka, Ajay K., Estell, Jane A., Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Medvedova, Eva, Weisel, Katja, Chiu, Christopher, Schecter, Jordan M., Amin, Himal, Qin, Xiang, Ukropec, Jon, Kobos, Rachel, Spencer, Andrew
Published in Clinical lymphoma, myeloma and leukemia (01.08.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2020)
Get full text
Journal Article
Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
Meininger, Gary E, Scott, Russell, Alba, Maria, Shentu, Yue, Luo, Edmund, Amin, Himal, Davies, Michael J, Kaufman, Keith D, Goldstein, Barry J
Published in Diabetes care (01.12.2011)
Published in Diabetes care (01.12.2011)
Get full text
Journal Article
Population pharmacokinetics and exposure–response analyses of daratumumab plus pomalidomide/dexamethasone in relapsed or refractory multiple myeloma
Dosne, Anne‐Gaelle, Li, Xia, Luo, Man Melody, Nnane, Ivo, Dimopoulos, Meletios A., Terpos, Evangelos, Sonneveld, Pieter, Kampfenkel, Tobias, Carson, Robin, Amin, Himal, Perez Ruixo, Juan, Zhou, Honghui, Sun, Yu‐Nien, Xu, Yan
Published in British journal of clinical pharmacology (01.05.2023)
Published in British journal of clinical pharmacology (01.05.2023)
Get full text
Journal Article
MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab + Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
Zamagni, Elena, Boccadoro, Mario, Spencer, Andrew, Delforge, Michel, Reece, Donna E., Gyula Szabo, Agoston, Einsele, Hermann, Terpos, Evangelos, Schjesvold, Fredrik, Bila, Jelena, Driessen, Christoph, Beksac, Meral, Cook, Gordon, Rodriguez, Cesar, Pei, Lixia, Shi, Yingqi, Sakabedoyan, Caline, Jasielec, Jagaoda, Amin, Himal, Kobos, Rachel, Sonneveld, Pieter, Van De Donk, Niels WCJ
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study
Sonneveld, Pieter, Terpos, Evangelos, Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Baldini, Luca, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Kampfenkel, Tobias, Qiu, Yanping, Amin, Himal, Kosh, Michele, Tran, NamPhuong, Carson, Robin, Dimopoulos, Meletios A.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial
Terpos, Evangelos, Dimopoulos, Meletios A., Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Pompa, Alessandra, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria‐Victoria, Einsele, Hermann, Orfanidis, Ioannis, Gries, Katharine S., Fastenau, John, Liu, Kevin, He, Jianming, Kampfenkel, Tobias, Qiu, Yanping, Amin, Himal, Carson, Robin, Sonneveld, Pieter
Published in American journal of hematology (01.04.2022)
Published in American journal of hematology (01.04.2022)
Get full text
Journal Article
Health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) treated with pomalidamide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes (PROs) in APOLLO
Terpos, Evangelos, Dimopoulos, Meletios A., Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Baldini, Luca, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Gries, Katharine S., Fastenau, John, Kampfenkel, Tobias, Qiu, Yanping, Amin, Himal, Sonneveld, Pieter
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Dimopoulos, Meletios A., Terpos, Evangelos, Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Baldini, Luca, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Ahmadi, Tahamtan, Ukropec, Jon, Kampfenkel, Tobias, Schecter, Jordan, Qiu, Yanping, Amin, Himal, Vermeulen, Jessica, Carson, Robin, Sonneveld, Pieter
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) Patients: An Update of Overall Survival in Castor
Lentzsch, Suzanne, Quach, Hang, Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Thiyagarajah, Piruntha, Amin, Himal, Casneuf, Tineke, Sonneveld, Pieter, Schecter, Jordan, Hungria, Vania T M
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies
Usmani, Saad Z., Mateos, Maria-Victoria, Lentzsch, Suzanne, Quach, Hang, Capra, Marcelo, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Qi, Ming, Amin, Himal, Wang, Jianping, Qin, Xiang, Okonkwo, Linda, Ukropec, Jon, Trivedi, Sonali, Suzuki, Kenshi, Dimopoulos, Meletios A, Cavo, Michele, Nooka, Ajay K, Chari, Ajai, Facon, Thierry
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in First Relapse Patients: Two-Year Update of Castor
Mateos, Maria-Victoria, Sonneveld, Pieter, Hungria, Vania T.M., Nooka, Ajay K, Estell, Jane, Barreto, Wolney G, Corradini, Paolo, Min, Chang-Ki, Medvedova, Eva, Weisel, Katja, Chiu, Christopher, Schecter, Jordan M., Amin, Himal, Qin, Xiang, Qi, Ming, Spencer, Andrew
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of Castor
Chanan-Khan, Asher A., Lentzsch, Suzanne, Quach, Hang, Horvath, Noemi, Capra, Marcelo, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Qi, Ming, Deraedt, William, Schecter, Jordan, Amin, Himal, Qin, Xiang, Casneuf, Tineke, Chiu, Christopher, Sasser, A. Kate, Sonneveld, Pieter
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Efficacy of Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Myeloma Based on Prior Lines of Therapy: Updated Analysis of Castor
Mateos, Maria-Victoria, Estell, Jane, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Medvedova, Eva, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Casneuf, Tineke, Chiu, Christopher, Sasser, A. Kate, Nooka, Ajay
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Daratumumab, bortezomib and dexamethasone (DVd) vs bortezomib and dexamethasone (Vd) in relapsed or refractory multiple myeloma (RRMM): Efficacy and safety update (CASTOR)
Lentzsch, Suzanne, Weisel, Katja C., Mateos, Maria-Victoria, Hungria, Vania, Munder, Markus, Nooka, Ajay K., Mark, Tomer, Quach, Hang, Scott, Emma Catherine, Lee, Je-Jung, Sonneveld, Pieter, Casneuf, Tineke, Chiu, Christopher, Qin, Xiang, Amin, Himal, Thiyagarajah, Piruntha, Schecter, Jordan Mark, Qi, Ming, Spencer, Andrew
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Twin randomized studies of daratumumab (DARA; D) plus standard of care (lenalidomide/dexamethasone or bortezomib/dexamethasone [DRd or DVd]) versus Rd or Vd alone in relapsed or refractory multiple myeloma (MM): 54767414MMY3003 (Pollux) and 54767414MMY3004 (Castor)
Palumbo, Antonio, Dimopoulos, Meletios A., Reece, Donna Ellen, Sonneveld, Pieter, Spencer, Andrew, Chanan-Khan, Asher Alban Akmal, Goldschmidt, Hartmut, Yeh, Howard, Schecter, Jordan Mark, Qin, Xiang, Amin, Himal, Guckert, Mary E., Ahmadi, Tahamtan, Orlowski, Robert Z.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article